274 related articles for article (PubMed ID: 15226292)
1. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
Yoshida H; Jono H; Kai H; Li JD
J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348
[TBL] [Abstract][Full Text] [Related]
3. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice.
Lim JH; Jono H; Koga T; Woo CH; Ishinaga H; Bourne P; Xu H; Ha UH; Xu H; Li JD
PLoS One; 2007 Oct; 2(10):e1032. PubMed ID: 17925880
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of JNK signaling by the tumor suppressor CYLD.
Reiley W; Zhang M; Sun SC
J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
[TBL] [Abstract][Full Text] [Related]
7. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways.
Chen R; Lim JH; Jono H; Gu XX; Kim YS; Basbaum CB; Murphy TF; Li JD
Biochem Biophys Res Commun; 2004 Nov; 324(3):1087-94. PubMed ID: 15485666
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha.
Watanabe T; Jono H; Han J; Lim DJ; Li JD
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3563-8. PubMed ID: 14993593
[TBL] [Abstract][Full Text] [Related]
9. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
Brummelkamp TR; Nijman SM; Dirac AM; Bernards R
Nature; 2003 Aug; 424(6950):797-801. PubMed ID: 12917690
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
11. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
[TBL] [Abstract][Full Text] [Related]
12. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
[TBL] [Abstract][Full Text] [Related]
13. CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.
Wang WY; Komatsu K; Huang Y; Wu J; Zhang W; Lee JY; Miyata M; Xu H; Li JD
PLoS One; 2014; 9(11):e112516. PubMed ID: 25389768
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
15. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
Imamura R; Konaka K; Matsumoto N; Hasegawa M; Fukui M; Mukaida N; Kinoshita T; Suda T
J Biol Chem; 2004 Nov; 279(45):46415-23. PubMed ID: 15337758
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
17. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
Nagabhushana A; Bansal M; Swarup G
PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway.
Mikami F; Gu H; Jono H; Andalibi A; Kai H; Li JD
J Biol Chem; 2005 Oct; 280(43):36185-94. PubMed ID: 16115866
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
20. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
